ImmuneBridge

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source…


Founded
2018
Headcount
18
Open roles
0
Last raised
Seed · $8M

SECTION I · THE BRIEF

Inside ImmuneBridge

Brief #90180Updated 18 NOV 2025SAN FRANCISCOMEDICAL ORGANIZATIONSSEED
Employbl Dossier

ImmuneBridge

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and…

Founded
2018
Headcount
18
Open roles
0
Last raised
Seed · $8M
Section II · Premium ProfileMembers only
  • 01Engineering interview process at ImmuneBridgeLocked
  • 02Tech stack & infrastructure choicesLocked
  • 03Culture & day-to-day work styleLocked
  • 04Why join now vs. 6 months from nowLocked
  • 05Hiring focus & open headcount by teamLocked
  • 06Comp philosophy and band contextLocked

7-day free trial · $25/mo · cancel anytime


LEADERSHIP

Founders & key people

Jesse CotariJesse Cotari
Peretz PartenskyPeretz Partensky

OPEN ROLES

Hiring at ImmuneBridge

No open roles listed right now. Check back soon or search all jobs →


FUNDING

Capital raised

Total Amount Raised: $17,632,000

ImmuneBridge's Investors

ImmuneBridge Funding Rounds

  • Seed

    $7,700,000

  • Series Unknown

    $5,632,000

  • Series Unknown

    $5,632,000

  • Seed

    $12,000,000

  • Seed

    $12,000,000

    Seed Investors

    Insight Venture Partners
    M Ventures
    One Way Ventures
    Gaingels
Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections ImmuneBridge is a part of. Click on the collection name to view similar companies.

ImmuneBridge's Investors


LOCATIONS

Where they work

ImmuneBridge Headquarters Location

2122 Bryant St, San Francisco, CA, 94110

Loading map…